Status:
NOT_YET_RECRUITING
Effectiveness of Tai Chi and Acupuncture on Migraine Attack Prevention and Brain White Matter Changes: A Non-Inferiority RCT
Lead Sponsor:
The Hong Kong Polytechnic University
Conditions:
Migraine
Migraine Disorder
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine the effectiveness of Tai Chi training and acupuncture on the migraine attacks and structural brain changes in women with episodic migraine. Researchers...
Detailed Description
The goal of this clinical trial is to determine whether Tai Chi training has the similar effectiveness in reducing the frequency of migraine attacks as acupuncture; and whether both Tai Chi and acupun...
Eligibility Criteria
Inclusion
- Chinese women aged 18 years and above;
- Diagnosed with episodic migraines, with or without aura, according to the International Classification of Headache Disorders, 3rd edition (ICHD-3);
- Migraine attack frequency ranging from 2 to 14 days per month (≥15 days/month is classified as chronic migraine and is not included in this study);
- Assessed by a sports specialist as capable of engaging in moderate physical activity;
- Residing in Hong Kong.
Exclusion
- Unable to engage in moderate physical activity;
- Comorbid with other neurological disorders;
- Experiencing non-migraine headaches for more than 5 days per month;
- Previous practice of Tai Chi or other mind-body exercises (such as yoga, biofeedback, meditation, etc.);
- Received alternative treatments for migraines (such as acupuncture or Chinese medicine) during the recruitment period or within the past 12 weeks;
- Undergoing preventive medication treatment for migraines during the recruitment period or within the past 12 weeks;
- Excessive use of medication, taking antipsychotic or antidepressant drugs, or using analgesics for other chronic pain conditions for more than 3 days per month within the past 12 weeks;
- Diagnosed with epilepsy or having a mental illness;
- Pregnant, breastfeeding, or currently taking contraceptive medication.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT06967909
Start Date
June 1 2025
End Date
September 1 2026
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic University
Hung Hom, Hong Kong, Hong Kong